Evidence map›Paper›PMID 36337938›Full record

ArticleRSC advances2022

Inhibition performance of halogen-substituted benzaldehyde thiosemicarbazones as corrosion inhibitors for mild steel in hydrochloric acid solution.

Honghong Zhang, Zhongnian Yang, Li Zhang, Wu Yue, Yanfeng Zhu, Xian Zhang

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Honghong ZhangDepartment of Chemical Engineering and Safety, Binzhou University Binzhou Shandong 256600 PR China bzuzhanghong@163.com +86-18766499800.ORCID https://orcid.org/0000-0003-1942-9598
Zhongnian YangDepartment of Chemical Engineering and Safety, Binzhou University Binzhou Shandong 256600 PR China bzuzhanghong@163.com +86-18766499800.
Li ZhangDepartment of Chemical Engineering and Safety, Binzhou University Binzhou Shandong 256600 PR China bzuzhanghong@163.com +86-18766499800.
Wu YueDepartment of Chemical Engineering and Safety, Binzhou University Binzhou Shandong 256600 PR China bzuzhanghong@163.com +86-18766499800.
Yanfeng ZhuDepartment of Chemical Engineering and Safety, Binzhou University Binzhou Shandong 256600 PR China bzuzhanghong@163.com +86-18766499800.
Xian ZhangDepartment of Chemical Engineering and Safety, Binzhou University Binzhou Shandong 256600 PR China bzuzhanghong@163.com +86-18766499800.
Binzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Halogen-substituted benzaldehyde thiosemicarbazone derivatives were synthesized and their inhibition performance for mild steel in hydrochloric acid solution were investigated systematically using weight loss measurements, electrochemical techniques, scanning electron microscopy and quantum chemical calculations. Results of weight loss measurements indicated that all these compounds exhibited excellent inhibition performance and the inhibition efficiency increased with increasing inhibitor concentrations. Polarization results revealed that the synthesized benzaldehyde thiosemicarbazone derivatives were mixed-type inhibitors. Adsorption of these compounds onto a mild steel surface was mainly chemisorption and complied with the Langmuir adsorption isotherms. Both theoretical calculations and experimental measurements suggested that the inhibition efficiency of these compounds followed the order of Br-BT > Cl-BT > F-BT > H-BT.

Identifiers

PMID36337938
PMCPMC9597289
OpenAlexW4308549701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.